Description of the medicine: De-Nol (De-Nol)
Colloidal bismuth subcitrate.
Synonyms: Bismuth tripotassium dicitrate, Biscolcitrat, Bismuthate tripotassium dicitrate, De-Noltal, Duosol, Tripotassium dicitrabismutate, Ulceron, etc.
Tribimol (Ttibimol) is similar in composition and action to De-nol.
De-nol has an antacid and enveloping effect. When taking the tablets inside, it gradually forms a colloidal mass distributed over the surface of the gastric mucosa, envelops the parietal cells; It has not only antacid, but also cytoprotective effect.
Indications for use are the same as for the tablets "Vicalin", "Vicair" and other similar drugs (see Sucralfate, Fosfalugel).
According to reports, de-nol is more effective in treating peptic ulcer of the stomach and duodenum than bismuth nitrate, which is due to its ability to better sanitize the mucous membranes of the stomach and duodenum from pyloric helico (campylo) bacteria. Recently, these pathogens have been given great importance in the pathogenesis of peptic ulcer.
Assign de nol 4 times a day: 1 to 2 tablets 1/2 to 1 hour before breakfast, lunch and dinner, and 1 to 2 tablets at bedtime. The course of treatment is 4-8 weeks.
Usually the drug is well tolerated; possible nausea, vomiting. Feces during treatment with the drug turns black. It is not recommended to use the drug for severe impaired renal function.
In order to avoid neurotoxic phenomena, you can not prescribe the drug for a long time in large doses.
Release form: tablets on 0,12 g.